ArticleOncotarget2017

Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution.

Jin-Xue He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.